Ireland vs Somalia: HIV/AIDS deaths averted by antiretroviral therapy
Ireland
333.89 deaths
in 2024
Somalia
336.41 deaths
in 2022
Ireland rank
99th
Somalia rank
98th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Ireland
- Somalia
How they compare
Somalia currently reports 336.41 deaths against 333.89 deaths in Ireland, a difference of 2.52 deaths.
The two have swapped places 2 times across 33 shared years of data; in 1990 it was Somalia ahead.
Ireland ranks 99th and Somalia ranks 98th of 157 countries.
Across the 4 decades both report, Ireland averaged higher in 2 and Somalia in 2.
Head to head by decade
| Decade | Ireland | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 20.43 deaths | 0 deaths | 20.43 deaths | Ireland |
| 2000s | 143.29 deaths | 33.63 deaths | 109.66 deaths | Ireland |
| 2010s | 229.99 deaths | 264.05 deaths | 34.06 deaths | Somalia |
| 2020s | 263.43 deaths | 331.82 deaths | 68.4 deaths | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Ireland or Somalia?
- Somalia, at 336.41 deaths against 333.89 deaths in Ireland as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Ireland and Somalia?
- 2.52 deaths, with Somalia ahead.
- How many years of comparable data are there for Ireland and Somalia?
- 33 years are reported by both, from 1990 to 2022.
- How do Ireland and Somalia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Ireland ranks 99th and Somalia ranks 98th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.